Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALGANCICLOVIR Cause Transplant dysfunction? 69 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Transplant dysfunction have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.9% of all adverse event reports for VALGANCICLOVIR.

69
Reports of Transplant dysfunction with VALGANCICLOVIR
0.9%
of all VALGANCICLOVIR reports
13
Deaths
17
Hospitalizations

How Dangerous Is Transplant dysfunction From VALGANCICLOVIR?

Of the 69 reports, 13 (18.8%) resulted in death, 17 (24.6%) required hospitalization, and 8 (11.6%) were considered life-threatening.

Is Transplant dysfunction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 69 reports have been filed with the FAERS database.

What Other Side Effects Does VALGANCICLOVIR Cause?

Off label use (1,882) Cytomegalovirus infection (1,091) Drug ineffective (886) Neutropenia (809) Leukopenia (574) Drug resistance (524) Cytomegalovirus viraemia (447) Pancytopenia (434) Cytomegalovirus infection reactivation (374) Death (359)

What Other Drugs Cause Transplant dysfunction?

TACROLIMUS (944) MYCOPHENOLATE MOFETIL (780) CYCLOSPORINE (610) SIROLIMUS (468) ETANERCEPT (449) DACLIZUMAB (421) INFLIXIMAB (405) PREDNISONE (240) TACROLIMUS\TACROLIMUS ANHYDROUS (198) THYMOCYTE IMMUNE GLOBULIN NOS (190)

Which VALGANCICLOVIR Alternatives Have Lower Transplant dysfunction Risk?

VALGANCICLOVIR vs VALIUM VALGANCICLOVIR vs VALPROATE VALGANCICLOVIR vs VALPROIC ACID VALGANCICLOVIR vs VALPROMIDE VALGANCICLOVIR vs VALSARTAN

Related Pages

VALGANCICLOVIR Full Profile All Transplant dysfunction Reports All Drugs Causing Transplant dysfunction VALGANCICLOVIR Demographics